Tamar Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
51,627
+2,544
| +5% | +$211K | 0.52% | 43 |
|
|
2025
Q1 | $3.98M | Buy |
49,083
+6,481
| +15% | +$526K | 0.54% | 43 |
|
|
2024
Q4 | $3.84M | Buy |
42,602
+1,081
| +3% | +$97.4K | 0.53% | 39 |
|
|
2024
Q3 | $4.1M | Buy |
41,521
+474
| +1% | +$46.8K | 0.58% | 39 |
|
|
2024
Q2 | $3.81M | Buy |
41,047
+1,278
| +3% | +$118K | 0.62% | 41 |
|
|
2024
Q1 | $3.77M | Sell |
39,769
-1,786
| -4% | -$169K | 0.64% | 40 |
|
|
2023
Q4 | $3.71M | Buy |
41,555
+6,859
| +20% | +$612K | 0.73% | 35 |
|
|
2023
Q3 | $2.53M | Buy |
34,696
+1,089
| +3% | +$79.5K | 0.61% | 39 |
|
|
2023
Q2 | $2.8M | Buy |
33,607
+30,574
| +1,008% | +$2.54M | 0.69% | 37 |
|
|
2023
Q1 | $231K | Buy |
3,033
+3
| +0.1% | +$229 | 0.07% | 50 |
|
|
2022
Q4 | $251K | Buy |
+3,030
| New | +$251K | 0.08% | 50 |
|